Craft
Intarcia Therapeutics

Intarcia Therapeutics

Market Valuation

$3.9 B

2016-09-15

Total Funding

$1.8 B

Intarcia Therapeutics Summary

Company summary

Overview
Intarcia Therapeutics is a biopharmaceutical company developing therapies for chronic diseases. Its flagship product, Medici Drug Delivery System, has the potential to transform the prevention and management of serious chronic diseases. The Сompany's products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady-state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity.
Type
Private
Status
Active
Founded
1997
HQ
Boston, MA, US | view all locations
Website
http://www.intarcia.com/
Cybersecurity rating
Sectors

Key people

  • Kurt Graves

    Kurt Graves, Chairman, President and CEO

    • Bryan Roberts, Director

      • Thomas Alessi

        Thomas Alessi, Vice President, Development and Manufacturing

        • Gino Santini, Director

          LocationsView all

          3 locations detected

          • Boston, MA HQ

            United States

            1 Marina Park Drive

          • Durham, NC

            United States

            6 Davis Dr

          • Hayward, CA

            United States

            24650 Industrial Blvd

          Footer menu